Platinum Diamond Photon (PDP)
The light of life born through research on the world's attention-grabbing "light" energy and the power of cutting-edge science!
The 21st century's next-generation substance emitting Far Biophoton.
Japan Institute for Industrial Resource Development
UCLA Nanotech Laboratory, U.S
the International Institute of Anticancer Research(IIAR)
Japanese company Biophoton has developed PDP fibers and PDP super-fine ceramics by combining nano-platinum and nano-diamond molecules. These are applied to various products such as clothing, bedding, and heating devices, allowing everyone to easily enjoy a Far Infrared Ray (FIR) light shower in their daily lives.
PDP has been recognized as the next-generation substance through clinical research by world-renowned scholars such as Dr. Mamdooh Ghoneum from UCLA, a global authority in immunology, and Professor James Gimzewski, a top authority in nanotechnology. Validation has been achieved through the International Institute of Anticancer Research (IIAR) and various testing laboratories.
What is a Far Infrared Ray (FIR)?
The wavelength of 4-14 μm in the light pouring from the sun is the most beneficial to the human body. This light is the Far Infrared Ray (FIR), an energy that nurtures and protects life.
"Light rays with wavelengths of 4 to 14 microns pouring from space to Earth are extremely effective in the human body, and are an absolute necessity for the survival of living organisms."
Biophoton refers to the Far Biophoton that sustain and nurture life.
Bio represents life, and Photon represents light.
Platinum Diamond Photon (PDP) Clinical Trials
Clinical papers resulting from joint research by Dr. Mamdooh Ghoneum, a global authority in immunology, and Professor James Gimzewski, a top authority in nanotechnology, have been submitted to the International Institute of Anticancer Research. These papers have been published in the academic journals "in vivo" and "Anticancer Research" released by the respective societies.
Through clinical experiments, PDP has been proven to increase the activity of NK cells, immune cells that directly destroy cancer cells. The first mouse experiment and the second human experiment clinical papers were officially published on the society's website in December 2009 and October 2010, respectively.
Academy Website Shortcut http://www.iiar-anticancer.orgPDP Colloid Solution (DPV576) was officially announced on July 19, 2013, as a clinical finding that eliminates resistance to cancer cell surfaces caused by anticancer drugs, published in the prestigious Nano Medicine.
Nano Medicine DPV576 View Google > Nano Medicine DPV576 SearchScientific Validation of PDP
Clinical papers resulting from joint research by Dr. Mamdooh Ghoneum, a global authority in immunology, and Professor James Gimzewski, a top authority in nanotechnology, have been submitted to the International Institute of Anticancer Research. These papers have been published in the academic journals "in vivo" and "Anticancer Research" released by the respective societies.
The International Institute of Anticancer Research (IIAR), headquartered in Greece, is one of the most prestigious societies globally. It rigorously evaluates and publishes clinical papers on substances that are inevitably the world's first in research and development related to cancer, leading to the award of the Nobel Prize.
Professor Luc Montagnier. France, for the discovery of the Human Immunodeficiency Virus.
Professor Harald Zur Haussen, for his discover of humman Papilloma Viruses causing cervical cancer.
Acquisition of International Patents for PDP
Complete international patents in
38 countries worldwide!